BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20669986)

  • 1. Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs.
    Wu G; Vashishtha SC; Erve JC
    Chem Res Toxicol; 2010 Aug; 23(8):1393-404. PubMed ID: 20669986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel metabolic bioactivation mechanism for a series of anti-inflammatory agents (2,5-diaminothiophene derivatives) mediated by cytochrome p450 enzymes.
    Hu Y; Yang S; Shilliday FB; Heyde BR; Mandrell KM; Robins RH; Xie J; Reding MT; Lai Y; Thompson DC
    Drug Metab Dispos; 2010 Sep; 38(9):1522-31. PubMed ID: 20530221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
    Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
    Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 oxidation of the thiophene-containing anticancer drug 3-[(quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic acid (4-trifluoromethoxy-phenyl)-amide to an electrophilic intermediate.
    Medower C; Wen L; Johnson WW
    Chem Res Toxicol; 2008 Aug; 21(8):1570-7. PubMed ID: 18672911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of bioactivation of ticlopidine using linear ion trap/orbitrap mass spectrometry and an improved mass defect filtering technique.
    Ruan Q; Zhu M
    Chem Res Toxicol; 2010 May; 23(5):909-17. PubMed ID: 20297803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of substituted thiophenes including α-chlorothiophene-containing compounds in human liver microsomes.
    Chen W; Caceres-Cortes J; Zhang H; Zhang D; Humphreys WG; Gan J
    Chem Res Toxicol; 2011 May; 24(5):663-9. PubMed ID: 21417487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen.
    O'Donnell JP; Dalvie DK; Kalgutkar AS; Obach RS
    Drug Metab Dispos; 2003 Nov; 31(11):1369-77. PubMed ID: 14570769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore.
    Graham EE; Walsh RJ; Hirst CM; Maggs JL; Martin S; Wild MJ; Wilson ID; Harding JR; Kenna JG; Peter RM; Williams DP; Park BK
    J Pharmacol Exp Ther; 2008 Aug; 326(2):657-71. PubMed ID: 18451316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes p450, and monoamine oxidases.
    Dalvie DK; O'Connell TN
    Drug Metab Dispos; 2004 Jan; 32(1):49-57. PubMed ID: 14709620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
    Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
    Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry.
    Alvarez-Diez TM; Zheng J
    Drug Metab Dispos; 2004 Dec; 32(12):1345-50. PubMed ID: 15328249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.
    Chen Q; Doss GA; Tung EC; Liu W; Tang YS; Braun MP; Didolkar V; Strauss JR; Wang RW; Stearns RA; Evans DC; Baillie TA; Tang W
    Drug Metab Dispos; 2006 Jan; 34(1):145-51. PubMed ID: 16251255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation.
    Chan CY; New LS; Ho HK; Chan EC
    Toxicol Lett; 2011 Oct; 206(3):314-24. PubMed ID: 21839818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of the phenothiazine antipsychotics chlorpromazine and thioridazine to electrophilic iminoquinone species in human liver microsomes and recombinant P450s.
    Wen B; Zhou M
    Chem Biol Interact; 2009 Oct; 181(2):220-6. PubMed ID: 19482014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First evidence that cytochrome P450 may catalyze both S-oxidation and epoxidation of thiophene derivatives.
    Dansette PM; Bertho G; Mansuy D
    Biochem Biophys Res Commun; 2005 Dec; 338(1):450-5. PubMed ID: 16137656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of sitaxentan in liver microsomes, hepatocytes, and expressed human P450s with characterization of the glutathione conjugate by liquid chromatography tandem mass spectrometry.
    Erve JC; Gauby S; Maynard JW; Svensson MA; Tonn G; Quinn KP
    Chem Res Toxicol; 2013 Jun; 26(6):926-36. PubMed ID: 23721565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine.
    Dragovic S; Boerma JS; van Bergen L; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2010 Sep; 23(9):1467-76. PubMed ID: 20849150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
    Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.